Interaction of human beta amyloid precursor protein (.beta.-app) with human lon-protease like protein (hslon)
CA 2332625 A1 · Owner: Nandabalan, Krishnan · Inventors: Nandabalan, Krishnan; Yang, Meijia; Schulz, Vincent Peter
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention discloses an interaction between .beta.-APP and HsLON and the formation of a .beta.-APP:HsLON complex or of the derivatives, fragments, analogs and homologs thereof that were identified using a , modified improved yeast two hybrid assay system. Methodologies of screening these aforementioned complexes for efficacy in treating and/or preventing various diseases and disorders, particularly neurodegenerative disease cardiomyopathy, diabetes, hearing loss male infertility, mitochondrial DNA , mutation associated disorders and the like are also disclosed herein.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 8, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 8, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 8, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.